# Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a company headquartered in Los Angeles, CA, United States.

## Company overview

- **Legal name:** Targeted Medical Pharma, Inc.
- **Former names in filing history:** AFH Acquisition III, Inc. (2008-02-01 to 2011-01-31)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Los Angeles, CA, United States
- **Fiscal year end:** December 9
- **SEC CIK:** 0001420030

## About

Targeted Medical Pharma, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001420030, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-04-14, it reported annual revenue of USD 5,260,941; net income of USD -3,043,810; total assets of USD 2,427,110 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $5.3M (USD 5,260,941)
- **Net income:** -$3.0M (USD -3,043,810)
- **Total assets:** $2.4M (USD 2,427,110)
- **Cash and equivalents:** $82,643 (USD 82,643)
- **Operating cash flow:** -$1.3M (USD -1,278,617)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $7.1M (USD 7,112,359)
- **Net income:** -$3.9M (USD -3,895,009)
- **Total assets:** $2.5M (USD 2,500,296)
- **Cash and equivalents:** $11,739 (USD 11,739)
- **Operating cash flow:** $780,314 (USD 780,314)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $9.6M (USD 9,555,562)
- **Net income:** -$9.3M (USD -9,337,618)
- **Total assets:** $5.0M (USD 4,997,753)
- **Cash and equivalents:** $491,806 (USD 491,806)
- **Operating cash flow:** -$2.0M (USD -2,046,586)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $7.3M (USD 7,296,401)
- **Net income:** -$9.6M (USD -9,586,182)
- **Total assets:** $11.8M (USD 11,775,360)
- **Cash and equivalents:** $326,603 (USD 326,603)
- **Operating cash flow:** -$2.4M (USD -2,373,401)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2019-05-17 — period 2019-05-14 — FORM 8-K
- Form 8-K — filed 2019-01-22 — period 2019-01-16 — 8-K
- Form 8-K — filed 2017-12-12 — period 2017-12-06 — FORM 8-K
- Form 10-K — filed 2016-04-14 — period 2015-12-31
- Form 10-Q — filed 2015-11-13 — period 2015-09-30
- Form 8-K — filed 2015-10-01 — period 2015-09-28
- Form 10-Q — filed 2015-08-14 — period 2015-06-30
- Form 10-Q — filed 2015-05-15 — period 2015-03-31
- Form 10-K — filed 2015-04-15 — period 2014-12-31
- Form 8-K — filed 2015-03-03 — period 2015-02-26
- Form 8-K — filed 2015-02-27 — period 2015-02-23
- Form 8-K — filed 2015-02-06 — period 2015-02-05

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/targeted-medical-pharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology